Powered by: Motilal Oswal
2025-04-17 09:11:16 am | Source: ARETE Securities Ltd
Stock Insights : Adani Wilmar Ltd, Bharat Heavy Electricals Ltd, Coforge Ltd, GlenmarTanla Platforms Ltd, k Pharmaceuticals Ltd, Manappuram Finance Ltd, UltraTech Cement Ltd, Zydus Lifesciences Ltd - ARETE Securities Lt
Stock Insights : Adani Wilmar Ltd, Bharat Heavy Electricals Ltd, Coforge Ltd, GlenmarTanla Platforms Ltd, k Pharmaceuticals Ltd, Manappuram Finance Ltd, UltraTech Cement Ltd, Zydus Lifesciences Ltd  - ARETE Securities Lt

Market Updates

The markets are expected to open marginally lower today as trendsin GIFT NIFTY indicate a negative start for the broader index afterNIFTY closed 108 points higher at 23,437 on Tuesday.

Adani Wilmar:

The company acquired 80% equity in G.D. Foods Manufacturing, making it asubsidiary as part of its phased acquisition strategy.

Bharat Heavy Electricals:

The company signed a Technology Transfer Agreement with BARC forindigenous electrolyser systems under the National Green Hydrogen Mission.

Coforge:

The company completed acquisition of 100% stake in Australia-basedTMLabs Pty Ltd through its subsidiary.

Glenmark Pharmaceuticals:

The company announced the US launch of Adderall-equivalent tablets invarious dosages starting May 2025.

Manappuram Finance:

The company received Rs.4,385 crore investment from Bain Capital, whichgains joint control post key approvals.

Roto Pumps:

The company launched its advanced ‘P’ Range compact pumps and unveilednext-gen infrastructure to target $100M revenue by 2028

SBI Cards & Payment Services:

The company partnered with Tata Digital to launch Tata Neu SBI Card,offering up to 10% NeuCoins on spends.

Tanla Platforms:

The company announced its first overseas deployment of rich mediamessaging platform MaaP with two global telcos.

UltraTech Cement:

The company agreed to acquire 26% equity in AMPIN C&I Power Eight tosecure renewable energy for captive use.

Waaree Renewables Technologies:

The company reported record revenue and PAT growth for FY25 and has anunexecuted orderbook of 3.2 GWp.

Zydus Lifesciences:

The company’s venture arm Zynext invested in Canada-based FeldanTherapeutics to advance intracellular drug delivery tech.

 

Please refer disclaimer at http://www.aretesecurities.com/

SEBI Regn. No.: INM0000127

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here